Early experience of intraoperative autotransfusion
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Introduction
Although acquired immunodeficiency syndrome (AIDS) has made the public aware of the dangers of homologous transfusion, the transmission of nonA nonB hepatitis which unlike AIDS is not detectable, is potentially a risk of greater magnitude. Unexplained rises of serum alanine aminotransferase (AST) occur in 10% of blood recipients! and 50% of these patients have long term persistent AST elevations. A proportion will develop chronic liver disease resulting in morbidity and costs to the health service. Homologous transfusion also carries the risk of alloimmunization and may compromise the survival of patients undergoing resection of carcinomas", These risks are proportional to the volume of transfused blood3,4 and may be avoided or reduced by autologous transfusion. Most patients expecting elective surgery can safely predeposit 2 or 3 units of blood within 4 weeks of surgery irrespective of their age", Autologous blood may also be collected during operation. There are 2 types of device available for intraoperative autotransfusion. The Haemonectics Cell Saver separates and washes red cells before returning them to the patient", It is a costly device requiring expert technical assistance and replaces only red cells. Whole blood replacement devices are less expensive, do not depend on expert assistance and are therefore more suitable to occasional use when there is an uncontaminated operative field. We have assessed the utility of one of these devices.
Patients and methods
Blood shed during operation was aspirated from the peritoneal cavity of 45 patients undergoing aortic surgery (n=41), nephrectomy (n=l), hepatic lobectomy (n=l), ruptured tubal pregnancy (n=l), and splenectomy (n=l). The 33 cases of elective aortic surgery received 10 000 units of heparin intravenously prior to aortic clamping. The remaining A P Wyatt MB FRCS cases except for the nephrectomy and one case of elective aortic surgery were emergency operations and did not receive heparin.
The blood was collected in a 500 ml Solcotrans bottle (Cabot Ltd) suspended from the Mayo stand. Low pressure suction (80-100 mmHg) was applied to the top portal and the blood aspirated from the peritoneal cavity taking care to avoid turbulence. Sixty millilitres of acid citrate dextrose formula A (ACD-A) anticoagulant solution was aspirated into the blood bag before blood collection. The full bottle was disconnected and handed to the anaesthetist who immediately transfused the blood through a 40 Jtm blood filter and standard administration set.
In 13 elective aortic cases, blood samples were taken from the patient at the start of the operation, from the Solcotrans bottle, the administration set after filtration and one hour postoperatively. Full blood count, platelet concentration, electrolyte concentration, fibrinogen, fibrin degradation products, liver function tests and coagulation studies were measured on each sample.
The data was analysed using a one way analysis of variance (ANOVA) to test for differences between samples. Spearman rank correlation (R.) was used for calculation of correlation coefficients.
Results
The mean blood loss of the 45 cases was 2.50 (SD 2.06) litres and 1.15 (SD 0.78) litres was autotransfused. One hundred and twenty one Solcotrans units were collected and 116 transfused. In 4 nonheparinized patients undergoing emergency aortic surgery 5 units 4 Paper read to Section of Surgery, 4 February 1987 were discarded because the blood clotted in the bottle despite the presence of anticoagulant. The majority of patients received 2 or 3 units. Overall 59% of the blood loss was reinfused. In the nonheparinized cases 30% of blood loss was returned against 61% in the heparinized cases. The amount of blood reinfused was approximately proportional to the bloodloss (Figure 1 ).
Thirty patients (67%) had additional homologous transfusion during or after operation. Six of these patients received a single unit transfusion which in retrospect was not necessary. Therefore 47% of the patients might have avoided homologous transfusion. Thirty-three per cent of the patients had a blood loss greater than 1 litre and would have required homologous transfusion if autotransfusion had not been available. Therefore 40% of the elective cases and 10% ofthe emergency cases would have required homologous transfusion if autotransfusion had not been available. All of the emergency cases of aortic surgery required homologous blood.
There were no complications attributable to the use of the device either during or after operation. There were 5 deaths. One case of multiple trauma with torn hepatic veins exsanguinated after completing right hepatic lobectomy, one ruptured abdominal aortic aneurysm exsanguinated whilst another developed a necrotic colon, and one elective aneurysm repair died of myocardial infarction. One patient died of acute renal failure, but this was present before emergency repair of a ruptured aortic aneurysm was undertaken. There were no other major complications. Table 1 shows the results of samples of blood taken before, during and after using the Solcotrans device in 13 patients undergoing elective aortic surgery. There was a 31% reduction in the concentration of erythrocytes in the bottle sample compared to the preoperative sample, but no significant alteration in the white cell or platelet counts. Potassium concentration increased presumably as a result of haemolysis. There was a 57% reduction of fibrinogen which correlated with increased fibrin degradation products (FDPs) <R.=0.7, P<0.05).
The alterations in sodium and calcium concentrations in the bottle samples probably reflect the presence of ACD-A. Filtration of the blood produced a significant fall in albumin concentration and small but insignificant decreases oferythrocyte, granulocyte, platelet and fibrinogen concentrations.
One hour postoperatively the majority of the measured parameters including prothrombin, partial thromboplastin and thrombin times had returned to normal. FDPs and bilirubin were still raised. There were too few patients not receiving homologous blood to determine what contribution homologous transfusion made to the final sample measurements.
Discussion
Intraoperative autotransfusion was described 130 years ago, but with the ready availability of homologous bank blood this technique has never been popular despite considerable researchl", The main problems have been the complexity of the early devices which used roller pumps to provide continuous reinfusion and difficulties in controlling the volume of anticoagulant. The Bentley device was withdrawn in 1979 after fatalities due to air embolus. The modern devices have been simplified, for example the Sorensen10 and Solcotrans" devices both use low pressure vacuum sources available in most operating theatres. The new pneumatically driven diaphragm pumps which are capable of continuous reinfusion of large volumes of blood cause less damage to the blood than the old roller pump designs!'.
Autotransfusion avoids the risks of alloimmunization, transfusion reactions and the transmission of infection. Even if homologous transfusion is required the risks can be reduced by the partial replacement of blood loss by autologous blood. Bank blood stored in an acid citrate solution has a potassium concentration of 17 mmol/litre after 2 weeks. The lower potassium concentration and warmth of autotransfused blood may be advantageous if there are large blood losses.
The proportion of blood reinfused fell with an increasing blood loss. In some unheparinized cases the blood clotted in the bottle despite the presence of anticoagulant. It may be important to heparinize the patient to prevent the initiation of coagulation before the blood is aspirated from the peritoneal cavity.
It is now doubtful whether the release of free haemoglobin and erythrocyte membranes resulting from haemolysis can by itself cause renal failure", but in the presence of sepsis or coexistent renal disease it is probably advisable to maintain a high urine output using dopamine and mannitol during and immediately after autotransfusion. In this study there was no evidence of clinically significant Although we were unable to show a significant fall in platelet and white cell concentration their functional capacity is unknown. On microscopy the platelets appear to be de granulated. This may be reversible and they may still be able to assist in providing haemostasis. It is doubtful whether the reinfusion of white cells would reduce the risk of postoperative infection. However it may reduce the risk in susceptible cases.
The defibrinogenation of blood aspirated from the peritoneal and pleural cavities is well knownl", but the mechanism remains obscure. The concomitant increase in fibrin degradation products suggests that low concentrations of thrombin may be generated with a resultant rapid defibrinogenation rather than primary fibrinogenolysis secondary to tissue plasminogen activator released from the mesothelium. Although defibrinogenation may reduce shear rates and blood cell damage there is a danger in massive transfusion of overwhelming defibrinogenation and loss of functional platelets. If more than 4 litres of autologous blood is transfused then replacement therapy with fresh frozen plasma is probably necessary. The measurement of platelet concentration may not indicate the need for platelet transfusion during intraoperative autotransfusion. The Solcotrans device provides a simple, safe and inexpensive method of autotransfusing 2 or 3 litres of blood aspirated from an uncontaminated operative field. Using this device homologous transfusion can be avoided in 40% of patients undergoing major vascular surgery.
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